Cannabix Technologies Inc. (BLOZF)
USD 0.41
(-5.16%)
USD 0.41
(-5.16%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 4.69 Million CAD | -32.35% |
| 2023 | 6.94 Million CAD | -20.7% |
| 2022 | 8.75 Million CAD | -15.62% |
| 2021 | 10.38 Million CAD | 18.83% |
| 2020 | 8.73 Million CAD | -39.99% |
| 2019 | 14.55 Million CAD | -3.62% |
| 2018 | 15.1 Million CAD | 98.82% |
| 2017 | 7.59 Million CAD | 18.3% |
| 2016 | 6.42 Million CAD | 27.16% |
| 2015 | 5.04 Million CAD | 1546.08% |
| 2014 | 306.78 Thousand CAD | 241.06% |
| 2013 | 89.95 Thousand CAD | -6.47% |
| 2012 | 96.16 Thousand CAD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 5.92 Million CAD | -7.65% |
| 2024 FY | 4.69 Million CAD | -32.35% |
| 2024 Q3 | 5.39 Million CAD | -9.01% |
| 2024 Q4 | 4.69 Million CAD | -12.86% |
| 2024 Q1 | 6.41 Million CAD | -7.62% |
| 2023 Q3 | 7.25 Million CAD | -5.6% |
| 2023 Q4 | 6.94 Million CAD | -4.28% |
| 2023 FY | 6.94 Million CAD | -20.7% |
| 2023 Q1 | 8.24 Million CAD | -5.85% |
| 2023 Q2 | 7.68 Million CAD | -6.79% |
| 2022 Q2 | 9.7 Million CAD | -5.28% |
| 2022 Q1 | 10.24 Million CAD | -1.27% |
| 2022 FY | 8.75 Million CAD | -15.62% |
| 2022 Q4 | 8.75 Million CAD | -4.27% |
| 2022 Q3 | 9.15 Million CAD | -5.75% |
| 2021 Q3 | 7.59 Million CAD | -3.68% |
| 2021 Q2 | 7.88 Million CAD | -4.86% |
| 2021 Q1 | 8.28 Million CAD | -5.16% |
| 2021 FY | 10.38 Million CAD | 18.83% |
| 2021 Q4 | 10.38 Million CAD | 36.72% |
| 2020 Q1 | 13.96 Million CAD | -4.07% |
| 2020 FY | 8.73 Million CAD | -39.99% |
| 2020 Q3 | 12.91 Million CAD | -3.56% |
| 2020 Q4 | 8.73 Million CAD | -32.37% |
| 2020 Q2 | 13.39 Million CAD | -4.09% |
| 2019 Q2 | 15.02 Million CAD | -1.95% |
| 2019 Q3 | 14.84 Million CAD | -1.22% |
| 2019 Q4 | 14.55 Million CAD | -1.91% |
| 2019 FY | 14.55 Million CAD | -3.62% |
| 2019 Q1 | 15.32 Million CAD | 1.45% |
| 2018 Q2 | 6.84 Million CAD | -5.72% |
| 2018 Q1 | 7.25 Million CAD | -4.49% |
| 2018 Q4 | 15.1 Million CAD | 16.77% |
| 2018 FY | 15.1 Million CAD | 98.82% |
| 2018 Q3 | 12.93 Million CAD | 89.1% |
| 2017 FY | 7.59 Million CAD | 18.3% |
| 2017 Q1 | 6.26 Million CAD | -2.43% |
| 2017 Q4 | 7.59 Million CAD | -3.04% |
| 2017 Q3 | 7.83 Million CAD | 15.36% |
| 2017 Q2 | 6.79 Million CAD | 8.39% |
| 2016 Q1 | 5.11 Million CAD | 1.32% |
| 2016 Q4 | 6.42 Million CAD | 36.04% |
| 2016 FY | 6.42 Million CAD | 27.16% |
| 2016 Q3 | 4.71 Million CAD | -4.04% |
| 2016 Q2 | 4.91 Million CAD | -3.87% |
| 2015 Q3 | 1.32 Million CAD | 4.98% |
| 2015 Q1 | 1.67 Million CAD | 445.12% |
| 2015 FY | 5.04 Million CAD | 1546.08% |
| 2015 Q4 | 5.04 Million CAD | 280.02% |
| 2015 Q2 | 1.26 Million CAD | -24.31% |
| 2014 Q1 | 87.55 Thousand CAD | -2.67% |
| 2014 Q2 | 85.01 Thousand CAD | -2.9% |
| 2014 FY | 306.78 Thousand CAD | 241.06% |
| 2014 Q4 | 306.78 Thousand CAD | -31.14% |
| 2014 Q3 | 445.5 Thousand CAD | 424.01% |
| 2013 FY | 89.95 Thousand CAD | -6.47% |
| 2013 Q4 | 89.95 Thousand CAD | 0.0% |
| 2012 FY | 96.16 Thousand CAD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Avitar, Inc. | 1.74 Million USD | -168.867% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| Manhattan Scientifics, Inc. | 316 Thousand USD | -1387.13% |
| Urologix, Inc. | 5.66 Million USD | 17.076% |
| ADM Tronics Unlimited, Inc. | 2.13 Million USD | -119.725% |
| Capital Group Holdings, Inc. | 33.79 Thousand USD | -13805.812% |
| CVR Medical Corp. | - USD | -Infinity% |
| Össur hf. | 1.39 Billion USD | 99.663% |
| Össur hf. | 1.39 Billion USD | 99.663% |
| SS Innovations International, Inc. | 25.47 Million USD | 81.556% |
| VMS Rehab Systems, Inc. | 4.45 USD | -105602821.348% |
| QHSLab, Inc. | 1.68 Million USD | -179.484% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| BrainsWay Ltd. | 62.97 Million USD | 92.537% |
| BioElectronics Corporation | 144.38 Thousand USD | -3154.654% |
| Hamilton Thorne Ltd. | 110.16 Million USD | 95.734% |
| Theraclion SA | 18.66 Million EUR | 74.821% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | 1.76 Million USD | -165.852% |
| Stratec SE | 529.71 Million USD | 99.113% |
| AVITA Medical, Inc. | 144.33 Million USD | 96.744% |
| Nu-Med Plus, Inc. | 2.21 Million USD | -112.444% |
| Zecotek Photonics Inc. | 2.57 Million USD | -82.648% |
| Wellstar International, Inc. | 957.89 Thousand USD | -390.591% |
| EKF Diagnostics Holdings plc | 102.92 Million USD | 95.434% |
| Escalon Medical Corp. | 4.75 Million USD | 1.232% |
| Guided Therapeutics, Inc. | 1.66 Million USD | -181.566% |
| Aurora Spine Corporation | 11.92 Million USD | 60.589% |
| NewCardio, Inc. | 2.85 Million USD | -64.712% |
| Vivos Inc. | 1.61 Million USD | -191.861% |
| MicroPort Scientific Corporation | 3.93 Billion USD | 99.88% |
| Kelyniam Global, Inc. | 1.63 Million USD | -187.827% |
| REMSleep Holdings, Inc. | 1.2 Million USD | -289.561% |
| CYduct Diagnostics, Inc. | 54.74 Thousand USD | -8483.565% |
| Nanomix Corporation | 982.05 Thousand USD | -378.52% |
| IR-Med Inc. | 999 Thousand USD | -370.403% |
| Wellness Center USA, Inc. | 182.18 Thousand USD | -2479.498% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 748.38 Thousand USD | -527.931% |
| Lombard Medical, Inc. | 67.76 Million USD | 93.065% |
| ALR Technologies Inc. | 193.21 Thousand USD | -2332.151% |
| Vycor Medical, Inc. | 992.29 Thousand USD | -373.581% |
| Heart Tronics, Inc. | 4.04 Million USD | -16.063% |
| Perimeter Medical Imaging AI, Inc. | 20.54 Million USD | 77.123% |
| SANUWAVE Health, Inc. | 22.41 Million USD | 79.036% |
| Ingen Technologies, Inc. | 737.73 Thousand USD | -536.992% |
| United American Healthcare Corporation | 10.37 Million USD | 54.723% |
| Odyssey Group International, Inc. | 455.79 Thousand USD | -931.023% |
| ECGI Holdings, Inc. | 5.2 Million USD | 9.653% |
| Polarean Imaging plc | 10.86 Million USD | 56.757% |
| Medical Supply International USA, Inc. | 870.77 Thousand USD | -439.675% |
| Rapid Therapeutic Science Laboratories, Inc. | 2.25 Million USD | -108.435% |
| Nexeon MedSystems Inc. | 20.35 Million USD | 76.909% |
| Qualis Innovations, Inc. | 2431.00 USD | -193208.515% |
| Smith & Nephew plc | 9.97 Billion USD | 99.953% |
| NIOX Group Plc | 116.47 Million USD | 95.966% |
| Fuse Medical, Inc. | 16.25 Million USD | 71.097% |
| Broncus Holding Corporation | 195.75 Million USD | 97.599% |
| Brain Scientific Inc. | 11.74 Million USD | 59.984% |
| Pressure BioSciences, Inc. | 1.04 Million USD | -347.693% |
| Health Logic Interactive Inc. | 28.73 Thousand USD | -16254.028% |